logo-loader

Avalon Globocare Corp seeing success working in the celltech space

Published: 17:23 10 Dec 2019 EST

Avalon GloboCare CEO (NASDAQ:AVCO) Dr. David Jin sat down with Proactive's Steve Darling at the 12th annual LD Micro Conference. The company is a clinical-stage CellTech bio-developer specializing in cellular therapeutics. Dr Jin talked about success in 2019 and what he expects in 2020.

Avalon Globocare enters 'transformative' deal to acquire majority stake in...

  Avalon GloboCare Corp (NASDAQ:AVCO) CEO Dr David Jin joins Proactive's Stephen Gunnion with details of a 'transformative' deal worth $31 million to acquire a 60% stake in Laboratory Services MSO and expand its focus on lab testing and services. Jin tells Proactive that...

on 11/08/2022